BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cosola C, Rocchetti MT, di Bari I, Acquaviva PM, Maranzano V, Corciulo S, Di Ciaula A, Di Palo DM, La Forgia FM, Fontana S, De Angelis M, Portincasa P, Gesualdo L. An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. Toxins (Basel) 2021;13:334. [PMID: 34063068 DOI: 10.3390/toxins13050334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Monteiro RC, Berthelot L. Role of gut-kidney axis in renal diseases and IgA nephropathy. Curr Opin Gastroenterol 2021;37:565-71. [PMID: 34482323 DOI: 10.1097/MOG.0000000000000789] [Reference Citation Analysis]
2 Rocchetti MT, Russo P, Spano G, De Santis L, Iarusso I, De Simone N, Brahimi S, Fiocco D, Capozzi V. Exploring the Probiotic Potential of Dairy Industrial-Relevant Lactobacilli. Applied Sciences 2022;12:4989. [DOI: 10.3390/app12104989] [Reference Citation Analysis]
3 Rocchetti MT. New Strategies for the Reduction of Uremic Toxins: How Much More We Know. Toxins (Basel) 2021;13:837. [PMID: 34941675 DOI: 10.3390/toxins13120837] [Reference Citation Analysis]
4 Zaidan N, Nazzal L. The Microbiome and Uremic Solutes. Toxins 2022;14:245. [DOI: 10.3390/toxins14040245] [Reference Citation Analysis]
5 Mafra D, Kalantar-Zadeh K, Moore LW. New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD. J Ren Nutr 2021;31:433-7. [PMID: 34294553 DOI: 10.1053/j.jrn.2021.07.002] [Reference Citation Analysis]